Newtopia Announces $10 Million in Series A Funding

Newtopia announced $10M in funding led by a syndicate of U.S. and Canadian institutional investors including Bloom Burton & Co, an investment banking firm specializing in the health sector, through its affiliated Bloom Burton Healthcare Lending Trust. Newtopia is a leading personalized health company that uses genetic testing and behavioral science to build highly personalized disease prevention plans for enterprise.
As quoted in the press release:

Founded by entrepreneurial and health innovator Jeff Ruby, Newtopia plans to grow the team internally and aggressively expand its geographic reach in the U.S. to revolutionize disease prevention programs in the workplace. Its health engagement platform is proven to significantly reduce corporate health costs by targeting employees at-risk for obesity, type 2 diabetes, heart disease and stroke (metabolic syndrome) and deliver effective ‘n of 1’ experiences for lifestyle management.
“I founded Newtopia with one goal in mind — to transform the way businesses engage in employee healthcare and disease prevention,” said Jeff Ruby, founder & CEO of Newtopia. “This investment will be used to fuel our continued growth and industry leading outcomes in the health care industry and accelerate the deployment of targeted disease prevention solutions. We will continue empowering at-risk employees to take charge of their health and well-being while simultaneously helping businesses save on rising employee health care costs.”
Newtopia’s program has been proven to improve key health metrics and produce in-year savings in medical costs and ROI for employers by offering a hyper-personalized approach that includes key factors such as genetics, personality, motivation, and readiness to change.

Click here for the full press release